On Monday, Shares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), skyrocketed 62.56% to $3.69.
OHR Pharmaceutical, declared positive final results from a Phase II investigator sponsored clinical trial of OHR-102 (0.2% Squalamine lactate ophthalmic solution) in patients with macular edema secondary to branch (BRVO) and central retinal vein occlusion (CRVO). The results demonstrated that, following an initial 10 week combination therapy treatment period, patients who continued to receive a combination of topical OHR-102 BID plus Lucentis(R) achieved greater visual acuity gains than the control group who received Lucentis alone. At week 38, the mean gain in visual acuity from baseline for patients randomized (at week 10) to treatment with OHR-102 + Lucentis PRN was +27.8 letters contrast with +23.3 for patients randomized to treatment with Lucentis plus PRN alone (control group), a clinically meaningful difference of +4.5 letters. The data were presented by John Wroblewski, MD, a retina specialist at Cumberland Valley Retina Consultants on Saturday, July 11 at the 2015 Annual Meeting of the American Society of Retina Specialists (ASRS) in Vienna, Austria.
OHR Pharmaceutical, Inc., a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its lead clinical program is OHR-102 eye drops, a novel therapeutic product, which could provide a non-invasive therapy to improve vision outcomes.
Shares of The Bank of New York Mellon Corporation (NYSE:BK), inclined 1.61% to $42.38, during its last trading session.
The Bank of New York Mellon Corporation, has extended its relationship with Raymond James & Associates, Inc. to provide sub-accounting services for more than $140 billion in assets and 6.4 million active investor positions.
BNY Mellon has been providing sub-accounting services to Raymond James since 2009 and also provides custody, credit and treasury services to the company.
BNY Mellon is the largest third-party provider of sub-accounting services in the U.S., as ranked by the 2015 Mutual Fund Service Guide. This is the fifth year BNY Mellon has achieved this ranking. BNY Mellon provides sub-accounting services to more than 130 million active positions with more than $2.6 trillion in assets.
The Bank of New York Mellon Corporation, an investment company, provides financial products and services to institutions, corporations, and high net worth individuals in the United States and internationally. It operates through two segments, Investment Administration and Investment Services.
Finally, United Continental Holdings, Inc. (NYSE:UAL), ended its last trade with 1.59% gain, and closed at $56.39, following reports that the airline industry was able to pocket a record $38.1 billion in extra fees in 2014, according to an annual study by IdeaWorksCompany and CarTrawler.
The $38.1 billion in fees collected is a 21% jump over the previous year and about a 15-fold enhance from the $2.45 billion in fees airlines collected in 2007.
In other news, United Airlines stated June 2015 operational results.
UAL’s June 2015 merged traffic (revenue passenger miles) raised 1.3 percent and merged capacity (accessible seat miles) raised 2.2 percent as compared to June 2014. UAL’s June 2015 merged load factor reduced 0.8 points contrast to June 2014.
United Continental Holdings, Inc., together with its auxiliaries, provides air transportation services in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
